pharmaceutical >   Products > Thalassemia

See Also

About Us

Machinery Products

Our Partners












Thalassemia are forms of inherited autosomal recessive blood disorders caused by the weakening and destruction of red blood cells in consequence of variant or missing genes that affect how the body makes hemoglobin. Lack of hemoglobin result in mild or severe anemia. Now mainly three chelating agents that we are focusing are:

  • Deferoxamin (intravenously)
  • Deferiprone (orally)
  • Deferasirox (orally)

 Our aim is not to be the provider of these routinely drugs but also several other new approaches as a good promising trends in the treatment of thalassemia.